Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy.
A J TempletonÁ Rodríguez-LescureA RuízE AlbaL CalvoM Ruíz-BorregoA SantaballaC A RodríguezC CrespoM RamosJ M Gracia-MarcoA LluchI ÁlvarezM I CasasM Sánchez-AragóR CaballeroE CarrascoE AmirM MartinAlberto Ocañanull nullPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
EudraCT: 2005-003108-12 (retrospectively registered 28/06/2005). ClinicalTrials.gov Identifier: NCT00129922 (retrospectively registered 10/08/2005). Results of this study were presented in part at the 2016 ESMO conference October 7-11, 2016, Copenhagen, Denmark (oral presentation).
Keyphrases